Carvedilol v metoprolol tartrate in chronic heart failure at mean 58 months*
| Outcomes | Carvedilol | Metoprolol tartrate | RRR (95% CI) | NNT (CI) |
|---|---|---|---|---|
| *Abbreviations defined in glossary; RRR, RRI, NNT, NNH, and CI calculated from data in article using Cox proportional hazards ratio. | ||||
| All cause mortality | 34% | 40% | 14% (5 to 21) | 19 (12 to 46) |
| Cardiovascular mortality | 29% | 35% | 17% (8 to 26) | 15 (10 to 31) |
| All cause mortality or all cause admission | 74% | 76% | 3% (−0.9 to 7) | Not significant |
| RRI (CI) | NNH | |||
| Non-cardiovascular mortality | 5% | 4% | 6% (−19 to 34) | Not significant |